Euro jumps as ECB goes easy, stocks little changed
By Caroline Valetkevitch NEW YORK (Reuters) - The euro climbed on Thursday as the European Central Bank disappointed some investors hoping for a bigger stimulus boost, while world equity indexes were near flat in choppy trading amid uncertainty over fresh U.S. economic stimulus.
By Caroline Valetkevitch
NEW YORK (Reuters) - The euro climbed on Thursday as the European Central Bank disappointed some investors hoping for a bigger stimulus boost, while world equity indexes were near flat in choppy trading amid uncertainty over fresh U.S. economic stimulus.
The ECB increased the overall size of its PEPP stimulus program by 500 billion euros ($605.7 bln) to 1.85 trillion euros ($2.2 trillion), in line with market expectations. It also extended the program by 9 months to March 2022, with the aim of keeping government and corporate borrowing costs at record lows.
The ECB also said it is monitoring the euro's exchange rate with regard to its possible implications for the medium-term inflation outlook.
Sterling weakened as investors became more cautious about the risk of a no-deal Brexit.
The euro was up 0.29% to $1.2116, while sterling was last trading at $1.3286, down 0.82% on the day.
On Wall Street, the S&P 500 was little changed, with focus on U.S. stimulus negotiations as an increase in weekly U.S. jobless claims pointed to a stalling labor market recovery.
"Any good news on the stimulus could usurp everything else and get us back to focusing on the potential for vaccines and the economic energy that will get released," said Art Hogan, chief market strategist at National Securities in New York. "But for now, we are held hostage to the gridlock in Washington."
U.S. lawmakers approved a stopgap government funding bill on Wednesday that would provide more time for negotiations. But an agreement has remained elusive due to disagreements over aid to state and local governments and business liability protections.
The Dow Jones Industrial Average fell 8.16 points, or 0.03%, to 30,060.65, the S&P 500 gained 5.43 points, or 0.15%, to 3,678.25 and the Nasdaq Composite added 90.81 points, or 0.74%, to 12,429.77.
The pan-European STOXX 600 index lost 0.28% and MSCI's gauge of stocks across the globe gained 0.18%.
Earlier, S&P Dow Jones Indices said it would remove 10 Chinese companies from its equities indices and several others from its bond indices overnight.
In the bond market, longer-dated Treasury yields were broadly lower.
Benchmark 10-year notes last rose 3/32 in price to yield 0.9328%, from 0.941% late on Wednesday.
Oil futures were higher, with Brent rising above $50 for the first time since March. Spot gold prices were slightly lower.
($1 = 0.8255 euros)
(Reporting by Caroline Valetkevitch; additional reporting by Karen Brettell in New York, Shriya Ramakrishnan in Bengaluru and Marc Jones in London; Editing by Larry King, Catherine Evans, Kirsten Donovan and Dan Grebler)
This story has not been edited by Firstpost staff and is generated by auto-feed.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
By Kate Holton LONDON (Reuters) - Britain reactivated emergency hospitals built at the start of the pandemic and shut primary schools in London on Friday to counter the rapid spread of a much more infectious variant of the coronavirus. With more than 50,000 new daily cases of COVID-19 for the last four days, the health service said it was preparing for an anticipated rush of patients and needed more beds.
By Susan Heavey WASHINGTON (Reuters) - Senator Mitt Romney on Friday urged the U.S. government to immediately enlist veterinarians, combat medics and others in a sweeping proposal to administer coronavirus vaccinations and slow the rising death toll.
DUBLIN (Reuters) - Ireland said on Friday it had under-reported coronavirus cases in recent days by thousands more than previously known as its system came under strain, suggesting the EU's fastest growing outbreak is worsening even more rapidly than figures showed.